Editor’s Note: In the first of two posts which offer new additions to former ‘Points’ feature ‘Hidden Figures of Drug History‘ Bob Beach explores the colorful career of Elizabeth Bass prior to her role as a G-Man within the Federal Bureau of Narcotics.
Editor’s Note: This situation report provides an overview of the current protocols at the National Archives in College Park, Maryland (Archives II). Please note this refers to Archives II only, as at early April 2022, and may be subject to change. Please check the NARA website for updates and communicate with the archives before making any definitive research plans. For further information and updates see: https://www.archives.gov/college-park.
Many thanks to Bill McAllister for agreeing to share his personal experiences/correspondence with the Points audience.
Author: Charles Ambler
On October 21, 2021 here on Points Sarah Brady Siff drew attention to an important new book by the eminent historian of medicine, Keith Wailoo, Pushing Cool: Big Tobacco, Racial Marketing, and the Untold Story of the Menthol Cigarette. In this book, Wailoo documents in lucid prose the cynical campaign by tobacco companies to market cigarette products in minority communities at a time when growing awareness of the health repercussions of tobacco use had led to sharp declines in smoking among white middle class Americans.
That domestic corporate strategy only represented a piece, and ultimately a relatively small piece, of a global effort to expand markets and find new sources of revenue outside the United States and Western Europe—in Asia, Latin America and Africa. Yet as my colleagues, Gernot Klantschnig and Neil Carrier, and I noted in the introduction to our collection on Drugs in Africa (2014) there is relatively little scholarship on tobacco production, manufacturing, promotion and consumption in Africa—not withstanding big tobacco’s supposed big push into the continent.
Editor’s Note: In this post, Dr Kawal Deep Kour shows the how the waning markets for rose attar and indigo positioned Ghazeepore, India, to take advantage of the emerging market for opium, and how attitudes towards production changed during the 19th century in response to the changing landscape of labor and colonialism.
Nestled within the orthogenetic city of Benaras, India, Ghazeepore (of the 19th century) was much like an entrepot or emporia without the spirit and brilliance of the former. Ghazeepore, developed independently though its attachment as a hinterland of Benaras, was valuable to the long-term growth under the British raj. But it was the accumulation of interconnected stories, as the social histories of roses, indigo and opium reveal, that facilitated the evolution of Ghazeepore as an influential city by the early 19th century.
The American Institute of the History of Pharmacy is pleased to announce the opening of the 2022 AIHP Glenn Sonnedecker Prize competition. The Glenn Sonnedecker Prize recognizes the author(s) of the best unpublished manuscript, on a topic within the field of the history of pharmacy and pharmaceuticals, submitted in the annual competition.
Today’s post features an interview with Toine Pieters, professor of the History of Pharmacy and Allied Sciences, acting head of the Freudenthal Institute, chairman of the board of the Graduate School of Natural Sciences and senior fellow of the Descartes Institute of the History and Philosophy of the Sciences and the Humanities at Utrecht University. His broader interests include drug and addiction research, neuropharmacology, leprosy research and the digital reuse of heritage resources.
Toine recently authored ‘THE BATTLE BETWEEN DAVID AND GOLIATH: Drug Making and the Dutch Pharmacist versus the International Pharmaceutical Industry, 1865–2020‘ within the first issue of History of Pharmacy and Pharmaceuticals. Find out more about Toine’s background, article and future research plans in this interview.